Anthony Busti, M.D., PHARM.D.
Pharmacotherapy Pharmacist in Baltimore, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 5,925 in Pharmacotherapy Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Anthony Busti, M.D., PHARM.D. reported a CMS MIPS final score of 82.6/100 - below the 83.1 national average - and filed 307 Medicare Part D claims in 2023.
- 82.6/100
- MIPS score · 0 vs avg
- 307
- Part D claims, 2023
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Anthony Busti, M.D., PHARM.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
83 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about Anthony Busti, M.D., PHARM.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Pharmacotherapy Pharmacist compares to other specialties among Maryland providers
Pharmacotherapy Pharmacist ranks #106 among Maryland's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Maryland provider total, by primary NUCC taxonomy. The highlighted bar is Pharmacotherapy Pharmacist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Anthony Busti, M.D., PHARM.D.'s 2023 MIPS final score plotted against the Pharmacotherapy Pharmacist national average
- MIPS Final Score
- 82.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pharmacotherapy Pharmacist) - 82.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Pharmacotherapy Pharmacist US NPIs
82.6/100 MIPS final score - 0.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pharmacotherapy Pharmacist. Quality dim: 79.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Anthony Busti, M.D., PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding M.D., PHARM.D. credentials at 1830 E MONUMENT ST # 6-100, Baltimore, MD, 21287, with a listed phone of (410) 955-3380. NPI 1861582512 was issued on 10/13/2006.
Medicare Part D records for calendar year 2023 show 307 prescription claims written by this provider, covering 199 Medicare beneficiaries and totaling roughly $5K in drug spend, with an opioid prescribing rate of 12.1%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.6/100 for the 2023 performance year (Quality 79.5), compared with the national average of 83.1.
Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1861582512 |
|---|---|
| Specialty | Pharmacotherapy Pharmacist |
| Credentials | M.D., PHARM.D. |
| Gender | Male |
| NPI Issued | 10/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Anthony Busti, M.D., PHARM.D.'s current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1861582512 is the unique 10-digit identifier CMS uses to link Busti across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Anthony Busti, M.D., PHARM.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 307
- Total Day Supply
- 2,042
- Generic Drug Cost
- $2K
- Opioid Claims
- 37 (12.1% rate)
- Antibiotic Claims
- 83
Patient Demographics
- Average Patient Age
- 70.1 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 49, 65-74: 77, 75-84: 56, 85+: 17
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Anthony Busti, M.D., PHARM.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ondansetron Odt
Ondansetron Odt
35 claims
- Prednisone
Prednisone
24 claims
- Methylprednisolone
Methylprednisolone
19 claims
- Tramadol Hcl
Tramadol Hcl
18 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
17 claims
- Acetaminophen-Code…
Acetaminophen-Codeine
16 claims
- Azithromycin
Azithromycin
15 claims
- Nitrofurantoin Mon…
Nitrofurantoin Mono-Macro
14 claims
| Drug | Claims |
|---|---|
| Ondansetron Odt Ondansetron | 35 |
| Prednisone | 24 |
| Methylprednisolone | 19 |
| Tramadol Hcl | 18 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 17 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 16 |
| Azithromycin | 15 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 14 |
| Levofloxacin | 13 |
| Ibuprofen | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacotherapy Pharmacist Overview
How Anthony Busti, M.D., PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.
Anthony Busti, M.D., PHARM.D.'s 307 claims are below the specialty average of 397.
Nearby Pharmacotherapy Pharmacist Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Busti.
Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Maryland medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pharmacotherapy Pharmacist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is Anthony Busti, M.D., PHARM.D.'s specialty? ▼
How much does Anthony Busti, M.D., PHARM.D. prescribe under Medicare Part D? ▼
What is Anthony Busti, M.D., PHARM.D.'s Medicare quality score? ▼
Where is Anthony Busti, M.D., PHARM.D. located? ▼
What is Anthony Busti, M.D., PHARM.D.'s NPI number? ▼
Does Anthony Busti, M.D., PHARM.D. prescribe opioids? ▼
How many Pharmacotherapy Pharmacist providers are there in the US? ▼
What drugs does Anthony Busti, M.D., PHARM.D. prescribe most often? ▼
Does Anthony Busti, M.D., PHARM.D. accept Medicare? ▼
How can I verify Anthony Busti, M.D., PHARM.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology